Skip to main content

Table 1 Clinical characteristics of COPD and control subjects

From: Upregulation of IL-17A/F from human lung tissue explants with cigarette smoke exposure: implications for COPD

 

COPD

Controls

Number

8

10

Age

63 ± 9

69 ± 8

Male/Female

3/5

6/4

Current/ex-smokers

5/3

2/7

Post-BD FEV1% predicted

78 ± 13

95 ± 17

GOLD Stage

  

I

4

-

II

3

-

III-IV

1

-

Respiratory Medication

  

SABD

3

-

LABD

3

-

ICS

2

-

Combination (LABD + ICS)

2

-

Theophylline

0

-

  1. Data are presented as mean ± SD. BD, bronchodilator; FEV1, forced expiratory volume in 1 s; TLCO, Transfer Factor of the Lung for Carbon Monoxide; SABD, short-acting bronchodilators; LABD, long-acting bronchodilators; ICS, inhaled corticosteroids.
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us